Treatment of ocular allergy

Immunology and Allergy Clinics of North America

Volumn 17, Issue 1, 1997, Pages 75-87

  Stock, E L ^a   Bielory, L ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE DRUG REACTION; ALLERGIC DISEASE; DIAGNOSTIC ACCURACY; EYE DISEASE; HUMAN; LYMPHOCYTE; MAST CELL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; TOPICAL DRUG ADMINISTRATION;

EID: 0031052412     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8561(05)70291-5     Document Type: Article

References (62)

1. M.B. Abelson R.S. Baird M.R. Allansmith Tear histamine levels in vernal conjunctivitis and other ocular inflammations Ophthalmology 87 1980 812 814
2. M.B. Abelson S.I. Butrus J.H. Weston Aspirin therapy in vernal conjunctivitis Am J Ophthalmol 95 1983 502 505
3. M.B. Abelson N.A. Madiwale J.H. Weston The effect of topical prostaglandin D2 on the eye [abstract] Invest Ophthalmol Vis Sci 22 1982 135
4. M.R. Allansmith J.V. Greiner R.S. Baird Number of inflammatory cells in the normal conjunctiva Am J Ophthalmol 86 1978 250 259
5. M.R. Allansmith R.N. Ross Ocular allergy and mast cell stabilizers Surv Ophthalmol 30 1986 229 244
6. R.G. Alvarez M.L. Arruzazabala Current views of the mechanism of action of prophylactic antiallergic drugs Allergol Immunopathol (Madr) 9 1981 501 508
7. E. Alvarez-Cuesta J. Cuesta-Herranz J. Puyana-Ruiz Monoclonal antibody-standardized cat extract immunotherapy: Risk benefit effects from double blind placebo study J Allergy Clin Immunol 93 1994 556 566
8. M. Azevedo M.G. Castel-Branco J.F. Oliveira Double-blind comparison of levocabastine eye drops with sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis Clin Exp Allergy 21 1991 689 694
9. Z. Ballas M. Blumenthal D. Tinkelman Clinical evaluation of ketorolac tromethamine (0.5%) ophthalmic solution for the treatment of seasonal allergic conjunctivitis Surv Ophthalmol 38 1993 141 148
10. D. BenEzra J. Pe'er M. Brodsky Cyclosporin eye drops for the treatment of severe vernal keratoconjunctivitis Am J Ophthalmol 101 1986 278 272
11. K. Bishop M. Abelson J. Cheetham Evaluation of flurbiprofen in the treatment of antigen-induced allergic conjunctivitis [abstract] Invest Ophthalmol Vis Sci 31 1990 487
12. J.H. Bleik K.F. Tabbara Topical cyclosporin in vernal keratoconjunctivitis Ophthalmology 98 1992 1679 1684
13. E. Bloch-Michel Evalaution de l'efficacite therapeutique d'un collyre anti-allergique par test photographique Revue Franchaise D'Aller Gologie 30 1990 163 165
14. M. Blumenthal T. Casale R. Dockhorn Efficacy and safety of Nedocromil sodium ophthalmic solution in the treatment of seasonal allergic conjunctivitis Am J Ophthalmol 113 1992 56 63
15. S. Bonini S. Bonini M. Schiavone Conjunctival hyperresponsiveness to ocular histamine challenge in patients with vernal conjunctivitis J Allergy Clin Immunol 89 1992 103 107
16. C.D. Brooks K.J. Karl Hay fever treatment with combined antihistamine and cyclooxygenase-inhibiting drugs J Allergy Clin Immunol 81 1988 1110 1117
17. D.C. Buckley D.R. Caldwell T.A. Reaves Jr Treatment of vernal conjunctivitis with suprofen, a topical nonsteroidal anti-inflammatory agent [abstract] Invest Ophthalmol Vis Sci 27 1986 29
18. D.R. Caldwell P. Verin R. Hartwich-Young Efficacy and safety of Lodoxamide 0.1% vs Cromolyn Sodium 4% in patients with vernal keratoconjunctivitis Am J Ophthalmol 113 1992 632 637
19. A.M. Campbell P. Demoly F.B. Micel Conjunctival provocation test with codeine phosphate: Effect of disodium cromoglycate Ann Allergy 71 1993 51 55
20. G. Ciprandi S. Buscaglia G. Pesce Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge J Allergy Clin Immunol 95 1995 612 621
21. G. Ciprandi C. Pronzato V. Ricca Terfenadine exerts antiallergic activity reducing ICAM-1 expression on nasal epithelial cells in patients with pollen allergy Clin Exp Allergy 25 1995 871 877
22. D.W. Cockcroft Bronchial inhalation tests I: Measurement of nonallergic bronchial responsiveness Ann Allergy 55 1985 527 534
23. S.E. Dahlen Drugs 37 1989 63 68
24. 2 by “lipocortins” and calpactins J Biol Chem 262 1987 1698 1705
25. S.P. Dhir S.K. Garg Y.R. Sharma N.K. Lath Prostaglandins in human tears Am J Ophthalmol 87 1979 403 404
26. J.P. Donovan D.L. Buckeridge M.P. Briscoe Efficacy of immunotherapy to ragweed antigen tested by controlled antigen exposure Ann Allergy Asthma Immunol 77 1996 74 80
27. S. Dreborg B. Agrell T. Foucard A double blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation: I: Clinical results Allergy 41 1986 131 140
28. D.L. Easty N.S.C. Rice B.R. Jones Clinical trials of topical Disodium cromoglycate in vernal keratoconjunctivitis Clinical Allergy 2 1972 99 107
29. A.J. Flack Cyclo-oxygenase inhibitors in ophthalmology Surv Ophthalmol 36 1992 259 284
30. G. Gillissen Disodium-cromoglycate and immune response mechanism Allergol Immunopathol (Madr) 10 1982 185 190
31. A.G. Gilman T.W. Rall A.S. Nies The pharmacological basis of therapeutics 1990 1442 1460
32. R. Gonzalez Alvarez W. Kazimierczak New light on the mechanism of action of disodium cromoglycate Agents Actions 11 1981 94 96
33. J. Greenbaum D. Cockcroft F.E. Hargreave Sodium cromoglycate in ragweed-allergic conjunctivitis J Allergy Clin Immunol 59 1977 437 439
34. 2 inhibitory protein in rabbit neutrophils induced by glucocorticoids Proc Natl Acad Sci 77 1980 2533 2536
35. 2 receptor Nature 349 1991 617 620
36. S.W. Hyams M. Bialik E. Neumann Clinical trials of disodium cromoglycate in vernal conjunctivitis J Pediatr Ophthalmol 12 1976 116
37. H.G. Johnson C.A. VanHout J.B. Wright Inhibition of allergic reactions by cromoglycate and by a new anti-allergy drug U-42,385E: Activity in rats Int Arch Allergy Immunol 56 1978 416 423
38. E.F. Juniper G.H. Guyatt P.J. Ferrie Sodium cromoglycate eye drops: Regular versus “as needed” use in the treatment of seasonal allergic conjunctivitis J Allergy Clin Immunol 94 1994 36 43
39. E.F. Juniper J. White J. Dolovich Efficacy of continuous treatment with astemizole (Hismanal) and terfenadine (Seldane) in ragweed pollen-induced rhinoconjunctivitis J Allergy Clin Immunol 82 1988 670 675
40. J.G. Kalpaxis T.O. Thayer Double-blind trial of pentigetide ophthalmic solution, 0.5%, compared with cromolyn sodium, 4%, ophthalmic solution for allergic conjunctivitis Ann Allergy 66 1991 392 398
41. N.I. Kjellman M.T. Stevens Clinical experience with Tilavist: An overview of efficacy and safety [review] Allergy 50 suppl 1995 14 22
42. P.J. Knudsen C.A. Dinarello T.B. Strom Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells J Immunol 139 1987 4129 4134
43. M. Leino C. Carlson E. Jaanio Double-blind group comparative study of 2% nedocromil sodium eye drops with placebo eye drops in the treatment of seasonal allergic conjunctivitis Ann Allergy 64 1990 398 402
44. R.A. Lewis L.J. Roberts S.T. Holgate Prostaglandin D2 production by rat and human mast cells activated by reversed anaphylaxis [abstract] Federation Proceedings 39 1980 905
45. 2 receptor agonist and antagonist binding in human platelets J Biol Chem 266 1991 13752 13758
46. D.M. Meisler U.J. Berzins J.H. Krachmer Cromolyn treatment of giant papillary conjunctivitis Arch Ophthalmol 100 1982 1608 1610
47. L. Noon B.O. Cantar Prophylactic inoculation against hay fever Lancet 1911 1572 1573
48. H.B. Ostler Acute chemotic reaction to cromolyn Arch Ophthalmol 100 1982 412 413
49. S.M. Panayotopoulos E.S. Panayotopoulos Efficacy of cetirizine in the treatment of seasonal allergic rhinoconjunctivitis Ann Allergy 55 1990 146 148
50. U. Pleyer S. Lutz W.J. Jusko Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eye Invest Ophthalmol Vis Sci 34 1993 2737 2742
51. B.M. Prenner Double-blind placebo-controlled trial of intranasal IgE pentapeptide Ann Allergy 58 1987 332 335
52. L.J. Roberts R.A. Lewis J.A. Oates Prostaglandin, thromboxane, and 12-hydroxy-5,8,10,14-eicosatetraenoic acid production by ionophore-stimulated rat serosal mast cells Biochim Biophys Acta 575 1979 185 192
53. L. Sautebin R. Carnuccio A. Ialenthi Lipocortin and vasocortin: Two species of anti-inflammatory proteins mimicking the effects of glucocorticoids Pharmacol Res 25 1992 1 12
54. S. Sawada G. Suzuki Y. Kawase Novel immunosuppressive agent FK506: In vitro effects on the cloned T cell population J Immunol 139 1987 1797 1803
55. M. Schoeneich A.R. Pecoud Effect of cetirizine in a conjunctival provocation test with allergens Clin Exp Allergy 20 1989 171 174
56. S.R. Schreiber Immunophilin-sensitive protein phosphatase action in cell signaling pathways Cell 70 1992 365 368
57. N.A. Sharif S. Xu J.M. Yanni Olopatadine (AL–4943A): Pharmacological profile of a novel antihistamine/antiallergic drug for use in allergic conjunctivitis Invest Ophthalmol Vis Sci 37 1996 S1027
58. E.M. Sorkin A. Ward Ocular sodium cromoglycate: An overview of its therapeutic efficacy in allergic eye disease Drugs 31 1986 131 148
59. Y. Sugimoto T. Namba A. Honda Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype J Biol Chem 267 1992 6463 6466
60. D. Tinkelman G. Rupp H. Kaufman Double masked paired comparative clinical study of ketorolac (0.5%) ophthalmic solution compared with placebo eye drops in the treatment of seasonal allergic conjunctivitis Surv Ophthalmol 38 1993 133 140
61. A.A. Verstappen J. Smith A. Rosenthal A double-masked efficacy and safety evaluation of lodoxamide 0.1% ophthalmic solution versus opticrom 2%: A multicenter study in patients with allergic eye disorders Alcon Report 8 1988 1287
62. T.S. Wood R.H. Stewart R.W. Bowman Suprofen treatment of contact lens-associated giant papillary conjunctivitis Ophthalmology 95 1988 822 826